158 related articles for article (PubMed ID: 1356959)
1. Estrogen receptor, c-erbB-2 and nm23/NDP kinase expression in the intraductal and invasive components of human breast cancers.
Kobayashi S; Iwase H; Itoh Y; Fukuoka H; Yamashita H; Kuzushima T; Iwata H; Masaoka A; Kimura N
Jpn J Cancer Res; 1992 Aug; 83(8):859-65. PubMed ID: 1356959
[TBL] [Abstract][Full Text] [Related]
2. Nm-23, c-erbB-2, and progesterone receptor expression in invasive breast cancer: correlation with clinicopathologic parameters.
Nakopoulou LL; Tsitsimelis D; Lazaris AC; Tzonou A; Gakiopoulou H; Dicoglou CC; Davaris PS
Cancer Detect Prev; 1999; 23(4):297-308. PubMed ID: 10403901
[TBL] [Abstract][Full Text] [Related]
3. Analysis of oncogenes and tumor suppressor genes in human breast cancer.
Yamashita H; Kobayashi S; Iwase H; Itoh Y; Kuzushima T; Iwata H; Itoh K; Naito A; Yamashita T; Masaoka A
Jpn J Cancer Res; 1993 Aug; 84(8):871-8. PubMed ID: 8104920
[TBL] [Abstract][Full Text] [Related]
4. p53 and c-erbB-2 protein expression in breast carcinomas. An immunohistochemical study including correlations with receptor status, proliferation markers, and clinical stage in human breast cancer.
Barbareschi M; Leonardi E; Mauri FA; Serio G; Dalla Palma P
Am J Clin Pathol; 1992 Oct; 98(4):408-18. PubMed ID: 1357956
[TBL] [Abstract][Full Text] [Related]
5. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
[TBL] [Abstract][Full Text] [Related]
6. Receptor status, proliferating activity, and c-erbB2 oncoprotein. An immunocytochemical evaluation in breast cancer.
Campani D; Sarnelli R; Fontanini G; Martini L; Cecchetti D; De Luca F; Squartini F
Ann N Y Acad Sci; 1993 Nov; 698():167-73. PubMed ID: 7904137
[No Abstract] [Full Text] [Related]
7. Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.
Wright C; Nicholson S; Angus B; Sainsbury JR; Farndon J; Cairns J; Harris AL; Horne CH
Br J Cancer; 1992 Jan; 65(1):118-21. PubMed ID: 1346366
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical study on the expression of c-erbB-2 oncoprotein in breast cancer.
Horiguchi J; Iino Y; Takei H; Yokoe T; Ishida T; Morishita Y
Oncology; 1994; 51(1):47-51. PubMed ID: 7903441
[TBL] [Abstract][Full Text] [Related]
9. C-erbB-2 protein and neuroendocrine expression in breast carcinomas.
Nesland JM; Ottestad L; Heikilla R; Holm R; Tveit K; Børresen AL
Anticancer Res; 1991; 11(1):161-7. PubMed ID: 1673329
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN
Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898
[TBL] [Abstract][Full Text] [Related]
11. c-myc, c-erbB-2, and Ki-67 expression in normal breast tissue and in invasive and noninvasive breast carcinoma.
Pavelic ZP; Pavelic L; Lower EE; Gapany M; Gapany S; Barker EA; Preisler HD
Cancer Res; 1992 May; 52(9):2597-602. PubMed ID: 1348967
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients.
Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T
Am J Surg; 1992 Oct; 164(4):323-6. PubMed ID: 1357997
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of expression of nm23-H1/nucleoside diphosphate kinase in human thyroid carcinomas: lack of correlation between its expression and lymph node metastasis.
Luo W; Matsuo K; Nagayama Y; Urano T; Furukawa K; Takeshita A; Nakayama T; Yokoyama N; Yamashita S; Izumi M
Thyroid; 1993; 3(2):105-9. PubMed ID: 8396479
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of estrogen receptor, progesterone receptor, HER2/neu, Ki-67, and nm23 expression in patients with invasive breast cancer.
Cubukcu E; Kanat O; Fatih Olmez O; Kabul S; Canhoroz M; Avci N; Deligonul A; Hartavi M; Cubukcu S; Olmez F; Kurt E; Evrensel T; Gokgoz S; Manavoglu O
J BUON; 2013; 18(2):359-65. PubMed ID: 23818346
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor expression in breast cancer: association with response to endocrine therapy.
Nicholson RI; McClelland RA; Gee JM; Manning DL; Cannon P; Robertson JF; Ellis IO; Blamey RW
Breast Cancer Res Treat; 1994 Jan; 29(1):117-25. PubMed ID: 7912565
[TBL] [Abstract][Full Text] [Related]
16. Increased erbB-2 gene copies and expression in multiple stages of breast cancer.
Iglehart JD; Kraus MH; Langton BC; Huper G; Kerns BJ; Marks JR
Cancer Res; 1990 Oct; 50(20):6701-7. PubMed ID: 2208136
[TBL] [Abstract][Full Text] [Related]
17. c-erbB-2 expression in breast cancer detected by immunoblotting and immunohistochemistry.
Kerns BJ; Pence JC; Huper G; Kinney RB; Iglehart JD
J Histochem Cytochem; 1990 Dec; 38(12):1823-30. PubMed ID: 1979342
[TBL] [Abstract][Full Text] [Related]
18. Detection of c-erbB-2 oncoprotein expression in breast tissue by multiparameter flow cytometry.
Li BD; Bauer KD; Carney WP; Duda RB
J Surg Res; 1993 Mar; 54(3):179-88. PubMed ID: 7682635
[TBL] [Abstract][Full Text] [Related]
19. Quantification of erbB-2/neu levels in tissue.
Paik S; King CR; Simpson S; Lippman ME
Methods Enzymol; 1991; 198():290-300. PubMed ID: 1677445
[No Abstract] [Full Text] [Related]
20. c-erbB-2 oncogene as a prognostic marker in breast cancer.
Perren TJ
Br J Cancer; 1991 Mar; 63(3):328-32. PubMed ID: 1672251
[No Abstract] [Full Text] [Related]
[Next] [New Search]
